NewsKanabo Buys National UK GP Online Service to Improve...

Kanabo Buys National UK GP Online Service to Improve Last Mile for Patients


  • Help available for conditions including chronic pain, anxiety and central nervous system diseases-
  • Ability to deliver electronic prescription across the UK to more than 4,000 pharmacies-
  • All GPs are in the UK and registered with the GMC-

Kanabo, the European medicinal cannabis company focusing on the development and distribution of cannabis-derived products for medical patients and wellness CBD consumers, has purchased The GP Service (GPS), one of the leading private telemedicine and online primary healthcare service providers in the UK.

The deal, announced today(MON), is worth £14m. Patients can, for a set price of £39.99, get an appointment with a UK registered GP within half an hour and then get a prescription sent to one of 4,200 pharmacies within an hour for £7.49.

Kanabo’s acquisition of The GP Service will facilitate the rapid growth of the existing GP digital and telemedicine business and will establish a new and fully compliant channel to market for Kanabo’s products for medical patients. Through improved access to these products, Kanabo hopes to make a substantial contribution to improving outcomes for thousands of patients in the UK and Europe.

GPS is an approved provider on the NHS digital framework for video and online consultations and is able to able to electronically deliver prescriptions to a network of 4,200 pharmacies including major high street chains and independent pharmacies

It provides online GP video consultation services to corporate clients as an occupational health service for employers as well as pharmacies.

Kanabo, the first medicinal cannabis company to IPO on the LSE, intends to develop The GP Service platform to become one of Europe’s first digitally-led and legally compliant providers for Kanabo’s products and wellness CBD services following regulatory approval.

The use of telemedicine has tremendous benefits for patients and has already been accelerated by the COVID-19 pandemic. The global telemedicine market is forecast to grow by 23% to $14.9 billion by 2024, and the UK market for private virtual GP services is estimated to be worth approximately £1 billion.

All the Doctors contracted by The GP Service are UK registered with the General Medical Council and all pharmacies affiliated with the services provided by the GP Service are also UK based and registered with the General Pharmaceutical Council.

Avihu Tamirfounder and CEO of Kanabo, said: “Today’s acquisition of the GP Service is part of our strategy to use M&A alongside organic growth to build a pan-European company, and to offer help to millions of consumers and medical patients for conditions including chronic pain, anxiety and central nervous system diseases.

“We are very much looking forward to working with the highly skilled team at GP Service to support the growth of their business in the rapidly growing tele-medicine market in the UK and beyond.

Atul Devani, CEO of the GP Service added:“The GP Service was incorporated with the aim of offering patients an innovative and cost-effective solution to access primary healthcare services conveniently and efficiently. We have invested heavily in our core systems and technologies to provide patients with treatment or advice following a remote video or with a GMC Registered Doctor and have successfully built one of the leading primary care telemedicine companies in the UK. With further support and investment from Kanabo we look forward to expanding our core service to cover a range of other medical conditions and further enhance our electronic prescription offerings in the coming months across a number of territories.”

Latest news

European Cannabis Stocks Review: Celadon Shares Spike 150% On Licence Update, OCT Continues Recovery, & Creso Pharma Censured By ASX

Celadon Pharmaceuticals  Celadon Pharmaceuticals stock has skyrocketed by more than 150% this week following the announcement that its current Home...

Benefits of F1 Cannabis Hybrids from Royal Queen Seeds

F1 hybrids have revolutionised the way we grow and use plants. Now, F1 cannabis seeds are bringing growers, smokers,...

Celadon Pharmaceuticals Announces Home Office Approval Of Licence For Commercial Sale Of GMP Cannabis

PRESS RELEASE FURTHER to the announcement dated 16 January 2023, Celadon Pharmaceuticals Plc (AIM: CEL), a UK-based pharmaceutical company focused on...

Proposed Changes To Germany’s Medical Cannabis Framework Would ‘Seriously Impact Both Patients And Industry’ If Brought In Tomorrow

TOMORROW, Germany’s Federal Joint Committee (G-BA) is expected to announce major changes to the country’s medical cannabis framework.  These could...

Will Twitter’s ‘Relaxation’ On Cannabis Advertising Help Break The Industry’s Social Media Ad Embargo?

TWITTER has become the first major social media platform to openly allow the advertisement of cannabis brands.  Since the new...

Kanabo Launches New Online Medical Cannabis Clinic ‘Treat It’, Offering Access To Doctors In ‘Less Than 24 Hours’

KANABO Group has today announced the launch of a new online medical cannabis clinic for pain management, Treat It.  The...

Must read

You might also likeRELATED
Recommended to you